South Africa Preclinical Cro Market Size & Outlook
South Africa preclinical cro market, 2018-2030 (US$M)
Related Markets
South Africa preclinical cro market highlights
- The South Africa preclinical cro market generated a revenue of USD 21.9 million in 2023 and is expected to reach USD 30.5 million by 2030.
- The South Africa market is expected to grow at a CAGR of 4.8% from 2024 to 2030.
- In terms of segment, toxicology testing was the largest revenue generating service in 2023.
- Bioanalysis and DMPK studies is the most lucrative service segment registering the fastest growth during the forecast period.
Preclinical cro market data book summary
| Market revenue in 2023 | USD 21.9 million |
| Market revenue in 2030 | USD 30.5 million |
| Growth rate | 4.8% (CAGR from 2023 to 2030) |
| Largest segment | Toxicology testing |
| Fastest growing segment | Bioanalysis and DMPK studies |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Bioanalysis and DMPK studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology |
| Key market players worldwide | Eurofins Scientific SE, Icon PLC, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Intertek Group PLC, Labcorp Holdings Inc, Crown Bioscience, SGA |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.4% of the global preclinical cro market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa preclinical cro market is projected to lead the regional market in terms of revenue in 2030.
- South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 30.5 million by 2030.
Toxicology testing was the largest segment with a revenue share of 22.83% in 2023. Horizon Databook has segmented the South Africa preclinical cro market based on bioanalysis and dmpk studies, toxicology testing, compound management, chemistry, safety pharmacology covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa is considered to be the largest market for pharmaceuticals in the Sub-Saharan African region. It has one of the most developed infrastructure facilities with the presence of a significant number of life sciences companies, such as Adcock Ingram, Aspen, and Genius Bio Therapeutics Ltd. Furthermore, the country has a developing healthcare and biotechnology market, which has led to increasing demand for preclinical trial services and drug discovery.
In this country, preclinical trials are widely conducted for diseases, such as cancer & cardiovascular diseases. Similarly, the increasing pool of clinical research and promoting partnerships among the pharmaceutical & medical device industries are driving the demand in the preclinical CRO market.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Preclinical CRO Market Scope
Preclinical CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Africa preclinical cro market size, by service, 2018-2030 (US$M)
South Africa Preclinical CRO Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
